Baseline characteristics of patients with transthyretin amyloidosis with cardiomyopathy in the CARDIO-TTRansform trial of eplontersen. - Fontana M; Ambardekar AV; Cappelli F; Cuddy SAM; Davis MK; Garcia-Pavia P; Hanna M; Khouri MG; Masri A; Maurer MS; Obici L; Solomon S; et al. (European journal of heart failure, 2026)